Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of sotagliflozin in symptomatic hypertrophic cardiomyopathy, including both obstructive and non-obst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: RECRUITING